FDA Approved: CESAMET — Supplemental Application (Bausch Health US LLC)

View source ↗

Summary

The FDA approved a supplemental application for Cesamet (nabilone) from Bausch Health US LLC, indicating an additional regulatory action for the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• CESAMET (nabilone)

Snippet

SUPPL AP for CESAMET (NABILONE)